Two-pronged attack on DNA repair could kill drug-resistant cancers 12 Mar 2020 Launching a two-pronged attack on cancer’s ability to safeguard its DNA could offer an effective new way of treating the disease, a new study reports. Find out more Show/Hide
ASCO 2019: ICR-discovered drug shows promise in phase I clinical trial 01 Jun 2019 A precision medicine targeting a key protein which helps cancer cells to tolerate DNA damage has shown promising results in two clinical trials. Find out more Show/Hide
Experimental drug could prevent cancer DNA repair to boost radiotherapy effects 03 Mar 2017 Treating bladder and head-and-neck cancers with an experimental drug called CCT244747 makes radiotherapy more successful at killing them, scientists have discovered. Find out more Show/Hide
ProNAi licenses oncology drug targeting DNA damage response Checkpoint kinase 1 (Chk1) from CRT Pioneer Fund, UK 28 Sep 2016